Volitionrx Ltd financial data

Symbol
VNRX on NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
Location
1489 West Warm Springs Road, Suite 110, Henderson, NV
State of incorporation
DE
Fiscal year end
December 31
Former names
STANDARD CAPITAL CORP (to 9/29/2011)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 39.7 % -51.2%
Debt-to-equity -216 % +97.2%
Return On Equity 170 % -95.2%
Return On Assets -165 % +1.1%
Operating Margin -2.33K % +56.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 92.7M shares +17.8%
Common Stock, Shares, Outstanding 92.4M shares +17.9%
Entity Public Float 82.2M USD +12%
Common Stock, Value, Issued 92.4K USD +17.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.29M USD +97.5%
Research and Development Expense 16.4M USD -16%
Selling and Marketing Expense 6.01M USD -9.22%
General and Administrative Expense 8.9M USD -9.39%
Costs and Expenses 803K USD
Operating Income (Loss) -30M USD +15%
Nonoperating Income (Expense) 51K USD -96.3%
Net Income (Loss) Attributable to Parent -30.2M USD +11.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.8M USD +17.6%
Accounts Receivable, after Allowance for Credit Loss, Current 313K USD +808%
Other Assets, Current 384K USD -22.1%
Assets, Current 6.8M USD -44.2%
Property, Plant and Equipment, Net 4.91M USD -7.48%
Operating Lease, Right-of-Use Asset 636K USD +29.6%
Intangible Assets, Net (Excluding Goodwill) 215K USD +137%
Assets 12.7M USD -29.7%
Accounts Payable, Current 2.49M USD -18.8%
Accrued Liabilities, Current 3.48M USD +21.4%
Contract with Customer, Liability, Current 96.2K USD
Liabilities, Current 30.3M USD +71.5%
Operating Lease, Liability, Noncurrent 448K USD +38.3%
Liabilities 35.3M USD +69.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 140K USD -41.5%
Retained Earnings (Accumulated Deficit) -224M USD -15.4%
Stockholders' Equity Attributable to Parent -21.5M USD -953%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -22.6M USD -694%
Liabilities and Equity 12.7M USD -29.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.34M USD +4.6%
Net Cash Provided by (Used in) Financing Activities -209K USD -103%
Net Cash Provided by (Used in) Investing Activities -78.8K USD +60.7%
Common Stock, Shares Authorized 175M shares +75%
Common Stock, Shares, Issued 92.4M shares +17.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.96M USD -946%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.41M USD -49.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 77.2K USD +50.5%
Operating Lease, Liability 709K USD
Depreciation 278K USD +10.6%
Payments to Acquire Property, Plant, and Equipment 28.8K USD -85.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30.3M USD +11.6%
Property, Plant and Equipment, Gross 9.94M USD +9.56%
Operating Lease, Liability, Current 219K USD +12.5%
Additional Paid in Capital 202M USD +5.48%
Amortization of Intangible Assets 14.3K USD -32.3%
Share-based Payment Arrangement, Expense 335K USD -32.2%
Interest Expense 155K USD +11.9%